ISSN: 2161-0495
Abel Andualem*, Seid Mufti Hussen, Rehima Mohammed Endris, Birhanu Geta Meharie
Introduction: Among pharmaceuticals that can induce liver injury or hepatotoxicity including anti-tubercular medications, general anesthetics, paracetamol, and some anti-cancer drugs. Liver can be damaged by certain chemicals known as hepatotoxins, such as galactosamine, alcohol and chloroform. Three pattern of injury are identified: Hepatocellular, cholestatic, and mixed. Mechanism of liver Injury caused by drugs may be direct (dosedependent, intrinsic, and predictable), idiosyncratic or indirect injury. The classic example of intrinsic liver injury is acetaminophen intoxication. Farnesoid X Receptor (FXR) is a regulator of hepatotoxicity and is used as therapeutic target in case of drug and alcohol induced hepatotoxicity. Many targets are also investigated as a potential therapeutic target in hepatotoxicity like CAR, LXR, PPARα and PXR. In addition, therapeutic strategies via inhibiting NLRP3 inflammasome is the protective effects of the phytochemicals for drug induced hepatotoxicity. In this review, updated researches on the molecular basis in hepatotoxicity of alcohol, drugs, food born mycotoxin and heavy metals were summarized followed by recent therapeutic targets associated with these agents.
Objective: The aim of this review is to offer a comprehensive review on molecular mechanism of hepatotoxicity, recent therapeutic target identified in clinical/preclinical setting and proposes new perspectives in the field of hepatotoxicity induced by alcohol, drugs, food born mycotoxin and heavy metals.
Published Date: 2026-06-19; Received Date: 2025-01-17